ArticleInternational journal of clinical and experimental pathology2014

Mig-6 overcomes gefitinib resistance by inhibiting EGFR/ERK pathway in non-small cell lung cancer cell lines.

Zi-Xuan Li et al.PubMed ↗Full text ↗

No numbers read from the abstract.